{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:28:05Z","timestamp":1785605285656,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4419,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.ymthe.2004.05.036","type":"journal-article","created":{"date-parts":[[2004,8,31]],"date-time":"2004-08-31T17:17:28Z","timestamp":1093972648000},"page":"492-499","source":"Crossref","is-referenced-by-count":45,"title":["Long-Term Correction of Ornithine Transcarbamylase Deficiency by WPRE-Mediated Overexpression Using a Helper-Dependent Adenovirus"],"prefix":"10.1016","volume":"10","author":[{"given":"Asad","family":"Mian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"W.Michael","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraj","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Kleppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Finegold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur L.","family":"Beaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2004.05.036_BIB1","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"1909","article-title":"Urea cycle enzymes","author":"Brusilow","year":"2001"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB2","series-title":"The NORD Guide to Rare Disorders","first-page":"505","article-title":"Urea cycle disorders","author":"Mian","year":"2003"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB3","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM198406073102304","article-title":"Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies","volume":"310","author":"Msall","year":"1984","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-3476(99)70448-8","article-title":"Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis","volume":"134","author":"Maestri","year":"1999","journal-title":"J. Pediatr"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00431-003-1347-z","article-title":"Outcome and survival of 88 patients with urea cycle disorders: A retrospective evaluation","volume":"162","author":"Bachmann","year":"2003","journal-title":"Eur. J. Pediatr"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1471-4914(02)02437-1","article-title":"Urea-cycle disorders as a paradigm for inborn errors of hepatocyte metabolism","volume":"8","author":"Mian","year":"2002","journal-title":"Trends Mol. Med"},{"issue":"1 Suppl.","key":"10.1016\/j.ymthe.2004.05.036_BIB7","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1067\/mpd.2001.111838","article-title":"Long-term correction of urea cycle disorders","volume":"138","author":"Lee","year":"2001","journal-title":"J. Pediatr"},{"issue":"Suppl. 2","key":"10.1016\/j.ymthe.2004.05.036_BIB8","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/PL00014323","article-title":"Liver transplantation in urea cycle disorders","volume":"158","author":"Saudubray","year":"1999","journal-title":"Eur .J. Pediatr"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1542\/peds.109.1.150","article-title":"An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency","volume":"109","author":"Scaglia","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB10","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1073\/pnas.96.7.3981","article-title":"Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemia","volume":"96","author":"Lee","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB11","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1074\/jbc.271.7.3639","article-title":"Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors","volume":"271","author":"Ye","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB12","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1172\/JCI118482","article-title":"Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes","volume":"97","author":"Morsy","year":"1996","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/hum.1996.7.7-821","article-title":"Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter","volume":"7","author":"Kiwaki","year":"1996","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB14","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/104303401750214267","article-title":"Differences in the human and mouse amino-terminal leader peptides of ornithine transcarbamylase affect mitochondrial import and efficacy of adenoviral vectors","volume":"12","author":"Ye","year":"2001","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB15","doi-asserted-by":"crossref","first-page":"14684","DOI":"10.1016\/S0021-9258(18)77356-0","article-title":"Ectopic correction of ornithine transcarbamylase deficiency in sparse fur mice","volume":"265","author":"Jones","year":"1990","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00063030-200216010-00001","article-title":"Improvements in gene therapy: averting the immune response to adenoviral vectors","volume":"16","author":"Ritter","year":"2002","journal-title":"BioDrugs"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB17","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/JVI.76.9.4580-4590.2002","article-title":"Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors","volume":"76","author":"Zaiss","year":"2002","journal-title":"J. Virol"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1006\/mthe.2001.0330","article-title":"Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors","volume":"3","author":"Schnell","year":"2001","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/mthe.2001.0329","article-title":"Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages","volume":"3","author":"Zhang","year":"2001","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol. Genet. Metab"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB21","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1089\/10430349950017455","article-title":"Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors","volume":"10","author":"Pastore","year":"1999","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/mthe.2002.0563","article-title":"Efficacy of gene therapy for a prototypical lysosomal storage disease (GSD-II) is critically dependent on vector dose, transgene promoter, and the tissues targeted for vector transduction","volume":"5","author":"Ding","year":"2002","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/10430340252899000","article-title":"Effect of promoters and enhancers on expression, transgene DNA persistence, and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-I","volume":"13","author":"Van Linthout","year":"2002","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1566523024605618","article-title":"Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy","volume":"2","author":"Amalfitano","year":"2002","journal-title":"Curr. Gene Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-2008-1040848","article-title":"Progress toward gene therapy of Duchenne muscular dystrophy","volume":"19","author":"Hartigan-O'Connor","year":"1999","journal-title":"Semin. Neurol"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB26","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1089\/10430349950016942","article-title":"Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy","volume":"10","author":"Loeb","year":"1999","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB27","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/JVI.72.6.5085-5092.1998","article-title":"Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element","volume":"72","author":"Donello","year":"1998","journal-title":"J. Virol"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB28","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1128\/MCB.22.7.2057-2067.2002","article-title":"CRM1-dependent function of a cis-acting RNA export element","volume":"22","author":"Popa","year":"2002","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB29","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1096\/fasebj.6.15.1281456","article-title":"Cell-specific expression of cytosolic phosphoenolpyruvate carboxykinase in transgenic mice","volume":"6","author":"Beale","year":"1992","journal-title":"FASEB J"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB30","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/MCB.12.3.1007","article-title":"Tissue-specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase\u2013human growth hormone fusion genes in transgenic mice","volume":"12","author":"Short","year":"1992","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB31","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1073\/pnas.97.3.1002","article-title":"Optimization of the helper-dependent adenovirus system for production and potency in vivo","volume":"97","author":"Sandig","year":"2000","journal-title":"Proc .Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB32","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/JVI.73.4.2886-2892.1999","article-title":"Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors","volume":"73","author":"Zufferey","year":"1999","journal-title":"J. Virol"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01846026","article-title":"Diagnostic value of orotic acid excretion in heritable disorders of the urea cycle and in hyperammonemia due to organic acidurias","volume":"134","author":"Bachmann","year":"1980","journal-title":"Eur. J. Pediatr"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB34","first-page":"743","article-title":"The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency","volume":"2","author":"Batshaw","year":"1995","journal-title":"Gene Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB35","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1128\/JVI.70.10.7209-7212.1996","article-title":"Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs","volume":"70","author":"Yang","year":"1996","journal-title":"J. Virol"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB36","first-page":"137","article-title":"Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo","volume":"3","author":"Yang","year":"1996","journal-title":"Gene Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB37","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","article-title":"Improved system for helper-dependent adenoviral vector production","volume":"8","author":"Palmer","year":"2003","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/10430340460732445","article-title":"Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates","volume":"15","author":"Brunetti-Pierri","year":"2004","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF02369439","article-title":"Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre","volume":"22","author":"Chen","year":"1996","journal-title":"Somat. Cell. Mol. Genet"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB40","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1073\/pnas.93.24.13565","article-title":"A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal","volume":"93","author":"Parks","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB41","first-page":"371","article-title":"Preparation of helper-dependent adenoviral vectors","volume":"69","author":"Ng","year":"2002","journal-title":"Methods Mol. Med"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/clinchem\/46.4.445","article-title":"Rapid screening of high-risk patients for disorders of purine and pyrimidine metabolism using HPLC\u2013electrospray tandem mass spectrometry of liquid urine or urine-soaked filter paper strips","volume":"46","author":"Ito","year":"2000","journal-title":"Clin. Chem"},{"key":"10.1016\/j.ymthe.2004.05.036_BIB43","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/ac60034a023","article-title":"Determination of creatine and creatinine","volume":"21","author":"Clark","year":"1959","journal-title":"Anal .Chem"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604002552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604002552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T10:03:57Z","timestamp":1624615437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001604002552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1525001604002552"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2004.05.036","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}